Grow your pharma business with targeted buyers Get Started
The U.S. recall began Sept. 24 and includes 22 tirzepatide lots and one lot of Apothecary NAD+ Injection.
This is a short summary. The full story is published by Econotimes.
Read full story at Econotimes
Apothecary Pharma is recalling 23 vials of compounded injectable drugs distributed nationwide because their sterility cannot be assured, according…
GSK has won FDA approval for its hepatitis B drug, which extended functional cures to far more patients than previous methods.
UNLOXCYT was approved by the US Food and Drug Administration (FDA) in 2024 for adults with metastatic or locally advanced cutaneous squamous cell…
Torrent Pharmaceuticals’ Q2 FY27 net profit fell 9.6% to Rs 534 crore, although revenue rose 50.8% to Rs 4,979 crore as expenses climbed 70.9%. Dr…
Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.
Exclusive introductory offer for new advertisers
Get offers from suppliers
Your product details and requirements may be published on the marketplace.
Fields marked with * are mandatory.